Business Context and Reporting Period
This Form 8-K filing by Pavmed Inc. (PAVM) is dated April 12, 2021. The company is an emerging growth company incorporated in Delaware with principal executive offices in New York. The filing primarily addresses corporate governance events rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the scheduling of the annual meeting of stockholders and does not contain financial statements or operational metrics.
Material Changes
There are no material financial changes reported in this document. The primary event is the announcement of the 2021 Annual Meeting of Stockholders, which is scheduled to be held virtually due to health concerns stemming from the COVID-19 pandemic.
Guidance, Outlook, and Management Commentary
- Annual Meeting Date: Tuesday, June 15, 2021.
- Meeting Format: Virtual only, accessible via a website to be specified in the proxy statement.
- Record Date: April 26, 2021, for stockholders eligible to vote.
- Stockholder Proposals (Rule 14a-8): Written notice must be delivered by the close of business on April 26, 2021.
- Director Nominations/Other Proposals: Notice must be received by April 22, 2021, in accordance with the company's bylaws.
Investor Verification Checklist
- Verify the specific website URL for the virtual Annual Meeting once the proxy statement is released.
- Confirm the exact deadline for submitting stockholder proposals (April 26, 2021) versus director nominations (April 22, 2021).
- Review the upcoming proxy statement for details on the agenda and voting procedures.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.